XGN
Exagen·NASDAQ
--
--(--)
--
--(--)
XGN fundamentals
Exagen (XGN) released its earnings on Nov 4, 2025: revenue was 17.24M (YoY +37.92%), beat estimates; EPS was -0.31 (YoY -10.71%), missed estimates.
Revenue / YoY
17.24M
+37.92%
EPS / YoY
-0.31
-10.71%
Report date
Nov 4, 2025
XGN Earnings Call Summary for Q3,2025
- Record Revenue Growth: Q3 2025 revenue up 40% YoY to $17.2 million, driven by 15% volume and 9% ASP expansion.
- Biomarker Innovation: New anti-PAD4 assays expand RA testing to 85% of patients, targeting $90 ASP uplift.
- Challenges: Lost high ASP account caused $20 ASP headwind, but October volume rebounded.
- Pharma Expansion: Pharma services revenue surged to $800k (vs. $100k in 2024), with $3.5M backlog.
- Gross Margin Target: Aiming for mid-60s gross margin via ASP expansion and cost efficiency.
EPS
Revenue
Revenue & Expenses
XGN has released its 2025 Q3 earnings report, with revenue of 17.24M, reflecting a YoY change of 37.87%, and net profit of -7.09M, showing a YoY change of -40.95%. The Sankey diagram below clearly presents XGN's revenue sources and cost distribution.
Key Indicators
Exagen (XGN) key financial stats and ratios, covering profitability, financial health, and leverage.
Exagen (XGN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Exagen (XGN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Exagen (XGN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Exagen (XGN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Exagen (XGN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Exagen's latest dividend and current dividend yield?What were the key takeaways from Exagen's earnings call?What is the revenue and EPS growth rate for Exagen year over year?What factors drove the changes in Exagen's revenue and profit?What does Exagen do and what are its main business segments?What is the market's earnings forecast for Exagen next quarter?What were the key takeaways from Exagen’s earnings call?What is Exagen's gross profit margin?
